Genmab | GEN - 営業経費

株価
1,702.50
毎日の変更
-38.00 -2.18%
毎月
-9.01%
毎年
20.40%
Q1 予測
1,638.96




営業経費 変化する 日付
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Almirall EUR 517.4M 32K 2025-12
Amarin USD 51.37M 14.6M 2025-09
Amgen USD 5.9B 773M 2025-12
argenx SE USD 914.57M 137.58M 2025-12
AstraZeneca USD 12.53B 4.16B 2025-12
Bayer EUR 10.33B 126M 2025-12
BioMarin Pharmaceutical USD 676.18M 131.65M 2025-12
Demant DKK 9.63B 241M 2025-12
Exelixis USD 362.75M 21.35M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
Galapagos EUR 120.26M 7.43M 2025-12
Genmab DKK 565M 38M 2025-06
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
GN Store Nord DKK 4.11B 490M 2025-12
GRIFOLS EUR 1.71B 193M 2025-12
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Insmed USD 513.55M 109.86M 2025-12
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.78B 669M 2025-12
Novartis USD 9.86B 115M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
UCB EUR 2.36B 108M 2024-12